Results 71 to 80 of about 442,357 (177)

Congress highlights : ESMO 2018 special edition : highlights in genitourinary cancers [PDF]

open access: yes, 2018
From the 19th till the 23rd of September, Munich was host for the 2018 ESMO Congress. The central theme of the congress was ‘Securing access to optimal cancer care’. This year’s venue was attended by more than 25,000 registered attendees.
Vermassen, Tijl, Rottey, Sylvie
core  

Hemorrhage and recent oncology diagnosis in individuals with atherosclerosis

open access: yesCurrent Issues in Pharmacy and Medical Sciences
Patients receiving antithrombotic therapy are at increased risk of bleeding. In some cases, bleeding may be the first manifestation of an underlying malignancy.
Jaffar Shaik
doaj   +1 more source

Immunotherapy in genitourinary cancers: Where are we going?

open access: yes, 2017
Introduction: Tumour-associated inflammation is involved with the development of genitourinary cancers. A growing understanding of the interactions between immune cells and cancer provides the basis for immunomodulating approaches.
Montironi R.   +8 more
core   +1 more source

Perceptions of COVID-19 Vaccination in Patients with Genitourinary Cancers: A Survey Study

open access: yes, 2023
Since the approval of the COVID-19 vaccines, their safety and efficacy has been widely demonstrated in patients with cancer. However, there remain patients with reservations regarding vaccination.
Errol J. Philip (9210992)   +18 more
core   +1 more source

Epidemiology of Genitourinary Tract Carcinoma in Siriraj Hospital During 1990-1995

open access: yesSiriraj Medical Journal, 2020
In Thailand genitourinary tract cancers are not as common as cancers of the liver and lung; but they affect the quality of life, well-being and mortality rate. If detected early, they can be cured by surgery.
Sonthidej Sivilaikul, Suchai Soontrapa
doaj  

Trends in genitourinary cancer mortality in the United States: analysis of the CDC-WONDER database 1999–2020

open access: yesFrontiers in Public Health
IntroductionSociodemographic disparities in genitourinary cancer-related mortality have been insufficiently studied, particularly across multiple cancer types.
Yahia Ghazwani   +36 more
doaj   +1 more source

Highlights in genitourinary cancers from the 2017 ASCO Genitourinary Cancers Symposium

open access: yes, 2017
From the 8th till the 12th of September, Madrid was the host city for the 2017 ESMO Congress. The central theme of the congress was ‘Integrating science into oncology for a better patient outcome’, as it is crucial that researchers and clinicians ...
Vermassen, Tijl, Rottey, Sylvie
core  

CHEMOTHERAPY OF ADVANCED GENITOURINARY CANCERS WITH CIS-DIAMMINEDICHLOROPLATINUM [PDF]

open access: yes, 1982
Eleven patients with advanced genitourinary cancers were treated with cis-diamminedichloroplatinum alone or in combination with other drugs or hormonal therapy or radiotherapy (4 patients with advanced nonseminomatous testicular tumors, two with ...
古武, 敏彦   +8 more
core  

Highlights in genitourinary cancer

open access: yes, 2022
The 2022 ASCO Annual Meeting again offered a variety of advancements in the treatment of genitourinary cancers. In this summary, some of the highlights in the fi eld of renal, bladder and prostate cancer will be discussed, with a particular focus on ...
De Maeseneer, Daan   +3 more
core  

Congress highlights : ASCO 2018 special edition : highlights in genitourinary cancers [PDF]

open access: yes, 2018
From June 1st till June 5th, Chicago was host for the 54th ASCO annual meeting. The theme for this year’s venue was ‘Delivering Discoveries: Expanding the Reach of Precision Medicine’. With more than 32,000 oncology professionals from around the world to
Vermassen, Tijl, Rottey, Sylvie
core  

Home - About - Disclaimer - Privacy